Loading
NB
Nerium Biotechnology, Inc. Stock: price and insider trades · Canada
Nerium Biotechnology, Inc.: what insiders have been doing
We have very little insider data for Nerium Biotechnology, Inc. so far: the most recent filing dates from 23 June 2017. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 23 June 2017
Declarations2 total
12,500 shares@ CA$2.00100.0% of flowCommon SharesTSXSEDI:3025469
Common SharesTSXSEDI:3025463
2 of 2 declarations
About Nerium Biotechnology, Inc.
Nerium Biotechnology, Inc. is a biotechnology company focused on developing innovative treatments for various diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.
